Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse.
about
Biodegradable polymeric microsphere-based vaccines and their applications in infectious diseasesChimeric flagellin expressed by Salmonella typhimurium induces an ESAT-6-specific Th1-type immune response and CTL effects following intranasal immunizationYersinia pestis (plague) vaccines.Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.Administration of antibody to the lung protects mice against pneumonic plague.Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred miceProtective Enterotoxigenic Escherichia coli Antigens in a Murine Intranasal Challenge Model.New age adjuvants and delivery systems for subunit vaccines.Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptorDesign and application of chitosan microspheres as oral and nasal vaccine carriers: an updated reviewPulmonary vaccine delivery.Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.Effect of Experimental Parameters on Alginate/Chitosan Microparticles for BCG Encapsulation.Immunization with the MipA, Skp, or ETEC_2479 Antigens Confers Protection against Enterotoxigenic E. coli Strains Expressing Different Colonization Factors in a Mouse Pulmonary Challenge Model.Nasal-nanotechnology: revolution for efficient therapeutics delivery.Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies.Mucosal vaccine delivery: Current state and a pediatric perspectiveIn vitro and ex vivo characterization of lectin-labeled Mycobacterium tuberculosis antigen-containing microspheres for enhanced oral delivery.Immune-stimulating potential of cell envelope proteins from Vibrio cholerae associated to chitosan microparticles: an in vitro study.Repertoire of HLA-DR1-restricted CD4 T-cell responses to capsular Caf1 antigen of Yersinia pestis in human leukocyte antigen transgenic mice.Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis.Sequential proteolytic processing of the capsular Caf1 antigen of Yersinia pestis for major histocompatibility complex class II-restricted presentation to T lymphocytes.Studies on the co-encapsulation, release and integrity of two subunit antigens: rV and rF1 from Yersinia pestis.Intranasal immunization against influenza virus using polymeric particles.Biodegradable microparticles with different release profiles: effect on the immune response after a single administration via intranasal and intramuscular routes.In vivo dysfunction of the term alveolar macrophage after in utero ethanol exposure.Strategies for vaccine delivery.
P2860
Q28087409-98EB875B-E26C-4874-B5EB-5E595297837BQ33577674-133223FB-BB3E-418F-8A0D-C973132EA59BQ34324211-4EF388E5-D261-4BE7-A2A6-1B54A587FEF8Q34334406-A4FC8799-ECFA-49C5-85F3-A669A9210A94Q34601788-D69D15AE-88AC-4283-9B47-02D4187C37D4Q35689282-287B801F-18E9-4B2D-A6B8-D0C897B581F9Q35920317-ED9BCBA6-9CFB-4152-9A25-B0B2D5CA1E3FQ36265526-E37606E5-C387-45A8-9469-126EBC4F53F2Q36288336-D6E1F2C5-AB97-4E65-A45C-E77D31757BDFQ36477627-A24C1E29-B2EE-43EA-A9C4-060DD1D34A8EQ36780141-E9ECAC68-0F9A-4AC7-B82F-670C7CAFF0AEQ36804213-182360BE-597C-4E58-AB6E-1BE63A4F95DDQ36941463-444CCCCE-DC03-48EE-B900-3A21D30A08E5Q37492013-1BE58712-7FF8-4FBB-AC86-DFEDF858DDC9Q38217878-D23F7FE0-5004-4060-85BF-3207FE91D3CEQ38461061-5538754E-ADE7-4A7E-B88A-65FA332D27ADQ38727453-EE9FD75B-9B83-402F-940E-2B8F68655B5DQ39103503-0C505F64-B013-4BF7-8664-213CBA5F9960Q39285727-4ED1368C-37D4-4853-A025-01F50802AC73Q41432988-D3F45167-D86A-4BDC-99DC-5654A28FF499Q41452700-0DCD8AEA-DBA7-4C51-B5F3-BA84FA40A6E9Q41453072-BFFA4DB9-B49D-4C96-8D8A-CDBEA7E28128Q41481485-8F53876F-178E-494E-ADE7-158FDF4C534DQ43970626-F5E9F7EE-A4D5-4155-A61D-869E71037773Q45812465-47258A3E-A099-414B-B401-93F5BDA549DBQ46739021-1FFF82FA-714A-4DBC-B504-87D99FA475FFQ47326792-08DA294D-13C6-46CB-B66D-AA93A8005615
P2860
Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Intra nasal administration of ...... pneumonic plague in the mouse.
@en
type
label
Intra nasal administration of ...... pneumonic plague in the mouse.
@en
prefLabel
Intra nasal administration of ...... pneumonic plague in the mouse.
@en
P2093
P1433
P1476
Intra nasal administration of ...... pneumonic plague in the mouse.
@en
P2093
E D Williamson
I D Spiers
P304
P356
10.1016/S0264-410X(97)00249-1
P407
P577
1998-04-01T00:00:00Z